• OPEN AN ACCOUNT
Indian Indices
Sensex
73,580.54 -1,247.71
( -1.67%)
Global Indices
Nasdaq
51,527.73 -356.96
(-0.69%)
Dow Jones
7,726.85 -58.79
(-0.76%)
Hang Seng
65,657.92 638.97
(0.98%)
Nikkei 225
10,680.49 -24.77
(-0.23%)
Forex
USD-INR
95.65 -0.17
(-0.17%)
EUR-INR
109.56 -0.37
(-0.34%)
GBP-INR
127.74 -0.44
(-0.34%)
JPY-INR
0.61 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Shah Foods Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
519031
INE455D01012
74.3639717
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
806.7
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

poonawalla fincorp limited
Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
May 13,2026
Net profit of Glaxosmithkline Pharmaceuticals rose 5.70% to Rs 277.86 crore in the quarter ended March 2026 as against Rs 262.87 crore during the previous quarter ended March 2025. Sales rose 2.15% to Rs 995.30 crore in the quarter ended March 2026 as against Rs 974.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.69% to Rs 1035.98 crore in the year ended March 2026 as against Rs 927.58 crore during the previous year ended March 2025. Sales rose 1.93% to Rs 3821.67 crore in the year ended March 2026 as against Rs 3749.21 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales995.30974.37 2 3821.673749.21 2
OPM %35.2634.20 -34.2631.40 -
PBDT386.27373.29 3 1451.831321.98 10
PBT373.10358.57 4 1385.391255.19 10
NP277.86262.87 6 1035.98927.58 12